Since Vechery founded the company in 2017, Modern Fertility has already been acquired for a number reported to exceed $225 million by patient-driven Telehealth company Ro (which is now valued at a whopping
$5 billion). Unsurprisingly, this is one of the most significant deals that the women's health space has seen to date, and in 2019, the company was awarded Fast Company's Most Innovative Health Company award. Today, the company has expanded its product offerings into other women's health categories like pregnancy and ovulation tests and a prenatal multivitamin. There's no denying that Vechery has catapulted women's health into a modern world, changing women's relationship with fertility for the better.